Pharmosa Biopharm Inc. (TPEX:6875)
Taiwan
· Delayed Price · Currency is TWD 52.20
+0.90 (1.75%)
Apr 2, 2025, 1:30 PM CST
Pharmosa Biopharm Market Cap
Pharmosa Biopharm has a market cap or net worth of 6.74 billion as of April 2, 2025. Its market cap has decreased by -47.50% in one year.
Market Cap
6.74B
Enterprise Value
5.24B
Revenue
167.57M
Ranking
n/a
PE Ratio
n/a
Stock Price
52.20
Market Cap Chart
Since February 22, 2022, Pharmosa Biopharm's market cap has increased from 4.86B to 6.74B, an increase of 38.70%. That is a compound annual growth rate of 11.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2025 | 6.62B | -3.02% |
| Dec 31, 2024 | 6.83B | -33.79% |
| Dec 29, 2023 | 10.31B | 46.19% |
| Dec 30, 2022 | 7.06B | 45.23% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 176.51B |
| Caliway Biopharmaceuticals | 113.99B |
| Bora Pharmaceuticals Co., LTD. | 71.78B |
| Lotus Pharmaceutical | 62.09B |
| Oneness Biotech | 32.98B |
| Lumosa Therapeutics | 29.22B |
| Pegavision | 28.08B |
| Polaris Group | 27.65B |